Wernsdorfer, Walther H.
Walther H Wernsdorfer
Wernsdorfer, Walther Helmut (1928-2016).
Wernsdorfer, Walter H.
VIAF ID: 190029603 (Personal)
Permalink: http://viaf.org/viaf/190029603
Preferred Forms
- 100 0 _ ‡a Walther H Wernsdorfer
-
- 100 1 _ ‡a Wernsdorfer, Walther H
- 100 1 _ ‡a Wernsdorfer, Walther H.
- 100 1 _ ‡a Wernsdorfer, Walther H.
- 100 1 _ ‡a Wernsdorfer, Walther H.
-
-
-
-
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Anti-leishmanial activity of plant-derived acridones, flavaglines, and sulfur-containing amides | |
Clinical and molecular characterization of a near fatal case of human babesiosis in Austria | |
Clinical and parasitological response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in rural Uganda. | |
Clinical features, aetiology and short-term outcome of interstitial pneumonitis in HIV/AIDS patients at Bamrasnaradura Hospital, Nonthaburi, Thailand | |
Coartemether (artemether and lumefantrine): an oral antimalarial drug | |
Comparative study on the in vitro activity of lumefantrine and desbutyl-benflumetol in fresh isolates of Plasmodium vivax from Thailand | |
Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border | |
Development of a pharmacodynamic screening model with Entamoeba histolytica | |
Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate. | |
Epidemiology and control of falciparum malaria in the Americas, 1984: | |
Epidemiology of drug-resistant malaria | |
Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan | |
From malaria control to eradication: The WHO perspective | |
Global challenges of changing epidemiological patterns of malaria | |
Histidine-rich protein II: a novel approach to malaria drug sensitivity testing | |
In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum | |
In vitro drug sensitivity testing in Plasmodium vivax | |
In-vitro response of Plasmodium falciparum to the main alkaloids of Cinchona in northwestern Thailand. | |
Investigation of the in vitro gender-specific partitioning of mefloquine in malarial infected red blood cells and plasma | |
Malaria at the turn from the 2nd to the 3rd millenium. | |
Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives. | |
Malaria : principles and practice of malariology | |
Malariological baseline survey and in vitro antimalarial drug resistance in Gulu district, Northern Uganda | |
Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro | |
Plasmodium falciparum: effect of anti-malarial drugs on the production and secretion characteristics of histidine-rich protein II. | |
Predictive role of laboratory and clinical treatment response parameters and glucose-6-phosphate dehydrogenase status in the therapy of falciparum malaria | |
Primaquine, c1986: | |
Primaquine : pharmakocinetics, metabolism, toxicity and activities : proceedings of a meeting of the Scientific Working Group on the Chemotherapy of Malaria, UNDP/WORLD BANK/WHO Special Programme for Research and Training in Tropical Diseases, held in Geneva, Switzerland, 27-28 February 1984 | |
Protection against malaria among seafarers | |
Relationships between mefloquine blood levels, gender, and adverse reactions | |
A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). | |
Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand | |
Synergistic interaction between monodesbutyl-benflumetol and retinol in Plasmodium falciparum | |
Thrombocyte counts in mice after the administration of papaya leaf suspension | |
Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults |